Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Individuals With X-linked Retinitis Pigmentosa (XLRP) Caused by RPGR-ORF15 Mutations

NCT03314207 is registered in ClinicalTrials.gov with Beacon Therapeutics as lead sponsor.

NCT NCT03314207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03314207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Individuals With X-linked Retinitis Pigmentosa (XLRP) Caused by RPGR-ORF15 Mutations
Lead sponsor
Beacon Therapeutics
Phase
Observational
Overall status
Completed
Start date
December 1, 2017
Completion date
February 10, 2022
Enrollment
14 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

x-linked retinitis pigmentosa